Call us now:
Eisai, a top 10 pharma in Japan announced it has suffered a Ransomware. The company pointed out that it is working to understand the impact of the attack on its consolidated earnings, a good indication that the hack may effect production.
Coming at a time when Eisai is awaiting FDA full approval of an Alzheimer’s drug. With a sharp rise in share price, markets do not appear to be concerned.
Ted Dziekanowski
#cybersecurity #cyberriskmanagement #cyberattack
View Original Post
https://www.linkedin.com/feed/update/urn%3Ali%3Ashare%3A7072871541666897920